XML 51 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
OPERATING ACTIVITIES:    
Net Income $ 32,043 $ 32,575
Items not affecting cash:    
Depreciation 26,433 25,315
Amortization of debt issue costs, discount and deferred hedge gain 90 398
Amortization of restricted stock 1,075 560
Equity portion of allowance for funds used during construction (930) (261)
Gain on disposition of assets (56) 0
Deferred income taxes 20,195 19,596
Changes in current assets and liabilities:    
Restricted cash 3,681 266
Accounts receivable 15,639 (1,421)
Inventories 17,856 23,848
Other current assets 1,153 (2,765)
Accounts payable (16,099) (17,369)
Accrued expenses 19,812 26,490
Regulatory assets 6,718 6,123
Regulatory liabilities (794) 6,014
Other noncurrent assets (13,717) (2,751)
Other noncurrent liabilities 6,826 5,462
Cash provided by operating activities 119,925 122,080
INVESTING ACTIVITIES:    
Property, plant, and equipment additions (47,107) (37,580)
Proceeds from sale of assets 80 0
Cash used in investing activities (47,027) (37,580)
FINANCING ACTIVITIES:    
Treasury stock activity 75 55
Dividends on common stock (13,358) (12,975)
Repayments on long-term debt (3,795) (3,623)
Line of credit borrowings 0 80,000
Line of credit repayments 0 (233,000)
(Repayments) issuances of short-term borrowings, net (53,956) 85,989
Cash used in financing activities (71,034) (83,554)
Increase in Cash and Cash Equivalents 1,864 946
Cash and Cash Equivalents, beginning of period 5,928 6,234
Cash and Cash Equivalents, end of period 7,792 7,180
Cash (received) paid during the period for:    
Income taxes (335) 0
Interest 8,806 9,584
Significant non-cash transactions:    
Capital expenditures included in accounts payable and accrued expenses $ 5,823 $ 1,695